Pediatric Immunization

COVID-19 Vaccines Safe and Effective in Children Aged 5-11 Years, According to New Research
February 06, 2023

Vaccination was associated with lower risks of infection, COVID-19-related illnesses, and hospitalizations due to COVID-19-related illnesses in children.

How to Handle Medical Misinformation in the Clinic
February 03, 2023

These tips from a family physician on managing misinformation in the exam room can help reduce the spread of false and misleading narratives.

AAFP President to Primary Care Clinicians: On Vaccines—Listen, Reassure, Advocate
January 30, 2023

The COVID-19 pandemic derailed routine immunizations and triggered a flood of vaccine misinformation beyond the COVID shot. Here, 3 ways to move forward.

It's Vaccination Catch-up Time for Kids: An APB from AAFP President Iroku-Malize
January 26, 2023

AAFP president Tochi Iroku-Malize, MD, MPH, MBA, urges gentle but persistent efforts among all clinicians to get school-aged children back on vaccination track.

The COVID-19 Vaccine Halo Effect: Survey Highlights
January 26, 2023

The Kaiser Family Foundation survey found a 10% drop in the proportion of adults who say MMR vaccination should be required for school attendance, and other "halo" effects.

Declining Kindergarten Vaccination Rate Leaves 250k Children Unprotected: AAFP President's Perspective
January 25, 2023

Tochi Iroku-Malize, MD, MPH, MBA, converts the 93% immunization rate for US kindergarteners into raw numbers of children now vulnerable to vaccine-preventable disease.

AAFP President Responds to Steady Decline in Vaccination Rates for Kindergarten-aged Children
January 24, 2023

AAFP president Dr Iroku-Malize discusses the proposed reasons for the 2-year decrease in immunization rates which include extended vaccine exemptions for some students.

FDA Grants BLA Review for Nirsevimab for RSV Prevention in Broad Infant Population
January 10, 2023

If approved, nirsevimab would be the first single-dose RSV preventative option for the broad newborn and infant population in the US.

Waning Protection from Pfizer-BioNTech COVID-19 Vaccine at 3 Months in Children is Restored, Sustained for 3 Months by Monovalent Booster
January 03, 2023

A new study points to the Pfizer shot's initially limited protection against the COVID-19 Omicron variant in those aged 5-11 years and also the the value of vaccine boosters.

FDA Authorizes Bivalent COVID-19 Vaccines as Booster Dose in Children Aged 6 Months to 5 Years
December 08, 2022

The FDA amended Pfizer and Moderna EUAs for updated COVID-19 vaccines to include children as young as age 6 months as holidays and winter weather approach.